Effect of Tumor Treating Fields (TTFields) (150 kHz) Concurrent With Standard of Care Therapies for Treatment of Stage 4 Non-small Cell Lung Cancer (NSCLC) Following Platinum Failure (LUNAR)
NovoCure Ltd.
NovoCure Ltd.
Bolt Biotherapeutics, Inc.
ImmuneSensor Therapeutics Inc.
DEKA Biosciences
BioAtla, Inc.
Jacobio Pharmaceuticals Co., Ltd.
VastBiome